Baba et al. first identified CD133 as a marker of ovarian CSC/TICs [27], and further studies [28,29] indicated that CD133 expression can define a tumor-initiating cell population in primary human ovarian tumors. This evidence concerns the gene PROM1 and ovarian neoplasm.